サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1651021

塞栓防止装置の世界市場

Embolic Protection Devices

出版日
ページ情報
英文 194 Pages
納期
即日から翌営業日
適宜更新あり
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円
塞栓防止装置の世界市場
出版日: 2025年02月07日
発行: Global Industry Analysts, Inc.
ページ情報: 英文 194 Pages
納期: 即日から翌営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

塞栓防止装置の世界市場は2030年までに21億米ドルに達する

2024年に14億米ドルと推定される塞栓防止装置の世界市場は、2024年から2030年にかけてCAGR 6.6%で成長し、2030年には21億米ドルに達すると予測されます。本レポートで分析したセグメントの1つである遠位フィルターは、CAGR 7.6％を記録し、分析期間終了までに13億米ドルに達すると予測されています。近位閉塞セグメントの成長率は、分析期間中CAGR 4.3％と推定されます。

米国市場は3億9,990万米ドルと推定、中国はCAGR6.2％で成長予測

米国の塞栓防止装置市場は、2024年には3億9,990万米ドルと推定されます。世界第2位の経済大国である中国は、分析期間2024-2030年のCAGRを6.2%として、2030年までに3億2,680万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ6.3%と5.2%と予測されています。欧州では、ドイツがCAGR 5.2%で成長すると予測されています。

世界の塞栓防止装置市場- 主要動向と促進要因のまとめ

塞栓防止装置は心血管治療にどのような革命をもたらしているのか？

塞栓防止装置（EPD）は、経皮的冠動脈インターベンション（PCI）や経カテーテル大動脈弁置換術（TAVR）などの手技の安全性と有効性を大幅に高めることで、心血管治療に革命をもたらしています。これらのデバイスは、これらのインターベンション中に外れる可能性のある塞栓の破片を捕捉・除去し、塞栓の破片が血流にのって移動し、脳卒中、心筋梗塞、臓器損傷などの合併症を引き起こすのを防ぐよう特別に設計されています。これによってEPDは、特に塞栓事象を起こしやすい高リスク患者において、心血管系処置に伴う主要なリスクの一つを軽減します。このような装置のイントロダクションは、手技合併症の発生率を低下させることによって患者の転帰を改善し、複雑な心血管系治療をより安全で効果的なものにしています。心血管疾患の世界の負担が増加し続ける中、患者の安全性を確保し、手技の成功率を高めるという塞栓防止装置の役割は、現代の心血管治療においてますます重要になってきています。

塞栓防止装置の機能性を高めるイノベーションとは？

塞栓防止装置のイノベーションは、デザイン、素材、他の心臓血管テクノロジーとの統合の進歩により、その機能性を高めています。最も重要な開発のひとつは、これらのデバイスの小型化であり、より小さな血管に、より高い精度と最小限の破壊で配置することを可能にしています。これは、頸動脈ステント留置術のように、脳卒中のリスクが高く、正確な留置が重要な手技において特に重要です。さらに、生体適合性ポリマーや微細なメッシュフィルターなどの先端材料の使用により、血流を阻害することなく最小の塞栓粒子でさえ捕捉するEPDの能力が向上しました。これにより、合併症のリスクを低減し、回復時間を改善する、より効果的で患者に優しいデバイスの開発につながった。さらに、塞栓防止装置と血管内超音波（IVUS）や光干渉断層計（OCT）などの画像技術との統合により、手技中のリアルタイムの視覚化が可能になりつつあります。この統合により、臨床医はEPDを正確に位置決めし、その性能をモニターすることができ、塞栓イベントに対する最適な保護を確保することができます。これらの技術革新により、塞栓防止装置はより効率的で、より使いやすく、より安全なものとなり、幅広い心臓血管インターベンションにおける役割を高めています。

塞栓防止装置は患者の治療成績と手技の安全性にどのような影響を与えますか？

塞栓防止装置は、心臓血管インターベンション中の塞栓合併症のリスクを大幅に減少させることにより、患者の転帰と手技の安全性に大きな影響を与えます。頸動脈ステント留置術、TAVR、PCIなどの手技において、プラークや血栓の脱落は、脳卒中や心臓発作を含む重篤な合併症につながる可能性があります。脳や冠動脈のような重要な部位に移動する前にこの破片を捕捉することで、EPDはこれらの有害事象の発生率を劇的に低下させる。この安全性プロファイルの改善は、患者の転帰を向上させるだけでなく、これまでハイリスクと考えられていた患者を含め、低侵襲心血管系処置の対象となる患者層を拡大します。さらに、EPDの使用は、患者が経験する合併症が少なく、術後の集中治療が少なくて済むため、入院期間の短縮と回復時間の短縮につながります。ヘルスケアプロバイダーにとっては、手技のリスクと関連合併症の減少は、全体的な成功率の向上と潜在的な医療費の削減につながります。塞栓防止装置は、心血管治療における最も重大なリスクの一つを回避することで、患者ケアの向上と救命処置の安全性向上に重要な役割を果たしています。

塞栓防止装置市場の成長を促進する動向とは？

塞栓防止装置市場の成長を牽引している動向には、心血管疾患の有病率の増加、低侵襲手技の採用拡大、医療技術の絶え間ない進歩などがあります。アテローム性動脈硬化症、心臓弁膜症、頸動脈狭窄症などの罹患率の上昇は、心血管インターベンションの件数の増加につながり、EPDの需要を押し上げています。世界の人口が高齢化し、心血管疾患の負担が増大するにつれ、安全で効果的な治療オプションの必要性がますます重要になっています。TAVRや頸動脈ステント留置術のような低侵襲手技へのシフトも市場成長に拍車をかけています。これらの手技は一般的に塞栓イベントのリスクが高く、患者の安全性を確保するためにEPDが不可欠だからです。さらに、濾過機能を強化し送達システムを改善した次世代EPDの開発など、デバイス設計の継続的な進歩により、これらのデバイスの用途と有効性が拡大しています。EPDの利点に関する規制当局の承認や医療従事者の意識の高まりは、市場拡大にさらに貢献しています。これらの動向は、重要な介入の安全性と成功率を高める上で極めて重要な役割を果たし続けるEPDが、心血管医療分野において重要性を増していることを裏付けています。

セグメント

タイプ（遠位フィルター、近位閉塞、遠位閉塞）、アプリケーション（心臓血管疾患、末梢血管疾患、神経血管疾患）

調査対象企業の例（注目の42社）

  • Abbott Laboratories, Inc.
  • Allium Medical Solutions Ltd.
  • AorticLab
  • Boston Scientific Corporation
  • Cardinal Health UK
  • Contego Medical, Inc.
  • Cordis, a Cardinal Health company
  • Duke Empirical, Inc.
  • Emboline Inc
  • Innovative Cardiovascular Solutions, LLC

目次

第1章 調査手法

第2章 エグゼクティブサマリー

  • 市場概要
  • 主要企業
  • 市場動向と促進要因
  • 世界市場の見通し

第3章 市場分析

  • 米国
  • カナダ
  • 日本
  • 中国
  • 欧州
  • フランス
  • ドイツ
  • イタリア
  • 英国
  • その他欧州
  • アジア太平洋
  • その他の地域

第4章 競合

目次
Product Code: MCP11766

Global Embolic Protection Devices Market to Reach US$2.1 Billion by 2030

The global market for Embolic Protection Devices estimated at US$1.4 Billion in the year 2024, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 6.6% over the analysis period 2024-2030. Distal Filter, one of the segments analyzed in the report, is expected to record a 7.6% CAGR and reach US$1.3 Billion by the end of the analysis period. Growth in the Proximal Occlusion segment is estimated at 4.3% CAGR over the analysis period.

The U.S. Market is Estimated at US$399.9 Million While China is Forecast to Grow at 6.2% CAGR

The Embolic Protection Devices market in the U.S. is estimated at US$399.9 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$326.8 Million by the year 2030 trailing a CAGR of 6.2% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 6.3% and 5.2% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 5.2% CAGR.

Global Embolic Protection Devices Market - Key Trends and Drivers Summarized

How Are Embolic Protection Devices Revolutionizing Cardiovascular Care?

Embolic protection devices (EPDs) are revolutionizing cardiovascular care by significantly enhancing the safety and efficacy of procedures like percutaneous coronary interventions (PCI) and transcatheter aortic valve replacements (TAVR). These devices are specifically designed to capture and remove embolic debris that may dislodge during these interventions, preventing it from traveling through the bloodstream and causing complications such as stroke, myocardial infarction, or organ damage. By doing so, EPDs mitigate one of the major risks associated with cardiovascular procedures, particularly in high-risk patients who are more susceptible to embolic events. The introduction of these devices has improved patient outcomes by reducing the incidence of procedural complications, thereby making complex cardiovascular treatments safer and more effective. As the global burden of cardiovascular disease continues to rise, the role of embolic protection devices in ensuring patient safety and enhancing procedural success is becoming increasingly important in modern cardiovascular care.

What Innovations Are Enhancing the Functionality of Embolic Protection Devices?

Innovations in embolic protection devices are enhancing their functionality through advancements in design, materials, and integration with other cardiovascular technologies. One of the most significant developments is the miniaturization of these devices, allowing them to be deployed in smaller blood vessels with greater precision and minimal disruption. This is particularly important in procedures like carotid artery stenting, where the risk of stroke is high and precise placement is crucial. Additionally, the use of advanced materials, such as biocompatible polymers and fine mesh filters, has improved the ability of EPDs to capture even the smallest embolic particles without impeding blood flow. This has led to the development of more effective and patient-friendly devices that reduce the risk of complications and improve recovery times. Furthermore, the integration of embolic protection devices with imaging technologies, such as intravascular ultrasound (IVUS) and optical coherence tomography (OCT), is enabling real-time visualization during procedures. This integration allows clinicians to accurately position EPDs and monitor their performance, ensuring optimal protection against embolic events. These innovations are making embolic protection devices more efficient, easier to use, and safer, enhancing their role in a wide range of cardiovascular interventions.

How Do Embolic Protection Devices Impact Patient Outcomes and Procedure Safety?

Embolic protection devices have a profound impact on patient outcomes and procedure safety by significantly reducing the risk of embolic complications during cardiovascular interventions. In procedures such as carotid artery stenting, TAVR, and PCI, the dislodgement of plaque or thrombus can lead to serious complications, including stroke or heart attack. By capturing this debris before it can travel to critical areas like the brain or coronary arteries, EPDs dramatically reduce the incidence of these adverse events. This improved safety profile not only enhances patient outcomes but also expands the pool of patients eligible for minimally invasive cardiovascular procedures, including those who were previously considered high-risk. Moreover, the use of EPDs can lead to shorter hospital stays and quicker recovery times, as patients experience fewer complications and require less intensive postoperative care. For healthcare providers, the reduction in procedural risks and associated complications translates into better overall success rates and potentially lower healthcare costs. By safeguarding against one of the most significant risks in cardiovascular interventions, embolic protection devices are playing a critical role in advancing patient care and improving the safety of life-saving procedures.

What Trends Are Driving Growth in the Embolic Protection Devices Market?

Several trends are driving growth in the embolic protection devices market, including the increasing prevalence of cardiovascular diseases, the growing adoption of minimally invasive procedures, and the continuous advancements in medical technology. The rising incidence of conditions such as atherosclerosis, heart valve diseases, and carotid artery stenosis is leading to an increase in the number of cardiovascular interventions, thereby boosting demand for EPDs. As the global population ages and the burden of cardiovascular diseases grows, the need for safe and effective treatment options is becoming more critical. The shift towards minimally invasive procedures, such as TAVR and carotid artery stenting, is also fueling market growth, as these procedures typically carry a higher risk of embolic events, making EPDs essential for ensuring patient safety. Moreover, ongoing advancements in device design, including the development of next-generation EPDs with enhanced filtration capabilities and improved delivery systems, are expanding the applications and effectiveness of these devices. Regulatory approvals and increasing awareness among healthcare providers about the benefits of EPDs are further contributing to market expansion. These trends underscore the growing importance of embolic protection devices in the field of cardiovascular medicine, as they continue to play a pivotal role in enhancing the safety and success of critical interventions.

SCOPE OF STUDY:

The report analyzes the Embolic Protection Devices market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Type (Distal Filter, Proximal Occlusion, Distal Occlusion); Application (Cardiovascular Diseases, Peripheral Vascular Diseases, Neurovascular Diseases)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; and Rest of Europe); Asia-Pacific; Rest of World.

Select Competitors (Total 42 Featured) -

  • Abbott Laboratories, Inc.
  • Allium Medical Solutions Ltd.
  • AorticLab
  • Boston Scientific Corporation
  • Cardinal Health UK
  • Contego Medical, Inc.
  • Cordis, a Cardinal Health company
  • Duke Empirical, Inc.
  • Emboline Inc
  • Innovative Cardiovascular Solutions, LLC

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Influencer Market Insights
    • Embolic Protection Devices - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
    • Global Economic Update
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Growing Prevalence of Cardiovascular Diseases Drives Demand for Embolic Protection Devices
    • Increasing Adoption of Minimally Invasive Surgical Techniques Bolsters Market Growth
    • Rising Global Health Awareness and Healthcare Access Enhancing Market Opportunities
    • Economic Factors Influencing Healthcare Spending and Device Adoption
    • Development of Next-Generation Embolic Protection Devices for Neurovascular Applications
    • Increasing Incidence of Atrial Fibrillation and Stroke Risk Management
    • Market Influence of Aging Populations on Cardiovascular Care
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Recent Past, Current & Future Analysis for Distal Filter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 2: World Historic Review for Distal Filter by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 3: World 15-Year Perspective for Distal Filter by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 4: World Recent Past, Current & Future Analysis for Distal Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 5: World Historic Review for Distal Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 6: World 15-Year Perspective for Distal Occlusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 7: World Recent Past, Current & Future Analysis for Proximal Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 8: World Historic Review for Proximal Occlusion by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 9: World 15-Year Perspective for Proximal Occlusion by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 10: World Recent Past, Current & Future Analysis for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 11: World Historic Review for Cardiovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 12: World 15-Year Perspective for Cardiovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 13: World Recent Past, Current & Future Analysis for Peripheral Vascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 14: World Historic Review for Peripheral Vascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 15: World 15-Year Perspective for Peripheral Vascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 16: World Recent Past, Current & Future Analysis for Neurovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 17: World Historic Review for Neurovascular Diseases by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 18: World 15-Year Perspective for Neurovascular Diseases by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World for Years 2015, 2025 & 2030
    • TABLE 19: World Embolic Protection Devices Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Embolic Protection Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Embolic Protection Devices by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Embolic Protection Devices by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific and Rest of World Markets for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 23: USA Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 24: USA Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 25: USA 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 26: USA Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 27: USA Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 28: USA 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 29: Canada Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 30: Canada Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 31: Canada 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 32: Canada Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 33: Canada Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 34: Canada 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • JAPAN
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 35: Japan Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Japan Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 37: Japan 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 38: Japan Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Japan Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 40: Japan 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • CHINA
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 41: China Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 42: China Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 43: China 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 44: China Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 45: China Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 46: China 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • EUROPE
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 47: Europe Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 48: Europe Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 49: Europe 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 50: Europe Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 51: Europe Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 52: Europe 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Embolic Protection Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Embolic Protection Devices by Geographic Region - France, Germany, Italy, UK and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Embolic Protection Devices by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK and Rest of Europe Markets for Years 2015, 2025 & 2030
  • FRANCE
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 56: France Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 57: France Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 58: France 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 59: France Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 60: France Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 61: France 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • GERMANY
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 62: Germany Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 63: Germany Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 64: Germany 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 65: Germany Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 66: Germany Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 67: Germany 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 68: Italy Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Italy Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 70: Italy 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 71: Italy Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Italy Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 73: Italy 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 74: UK Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 75: UK Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 76: UK 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 77: UK Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 78: UK Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 79: UK 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 80: Rest of Europe Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 81: Rest of Europe Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 82: Rest of Europe 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 83: Rest of Europe Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 84: Rest of Europe Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 85: Rest of Europe 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Embolic Protection Devices Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 86: Asia-Pacific Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Asia-Pacific Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 88: Asia-Pacific 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 89: Asia-Pacific Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Asia-Pacific Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 91: Asia-Pacific 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030
  • REST OF WORLD
    • TABLE 92: Rest of World Recent Past, Current & Future Analysis for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Rest of World Historic Review for Embolic Protection Devices by Type - Distal Filter, Proximal Occlusion and Distal Occlusion Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 94: Rest of World 15-Year Perspective for Embolic Protection Devices by Type - Percentage Breakdown of Value Sales for Distal Filter, Proximal Occlusion and Distal Occlusion for the Years 2015, 2025 & 2030
    • TABLE 95: Rest of World Recent Past, Current & Future Analysis for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Rest of World Historic Review for Embolic Protection Devices by Application - Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
    • TABLE 97: Rest of World 15-Year Perspective for Embolic Protection Devices by Application - Percentage Breakdown of Value Sales for Cardiovascular Diseases, Peripheral Vascular Diseases and Neurovascular Diseases for the Years 2015, 2025 & 2030

IV. COMPETITION